Related Experiment Videos
Acceptability of the Woman's Condom in a phase III multicenter open-label study
Beatrice A Chen1, Diana L Blithe2, Gitonga R Muraguri3
1Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, 300 Halket Street, Pittsburgh, PA, USA; Magee-Womens Research Institute, 204 Craft Avenue, Pittsburgh, PA, USA.
Contraception
|March 9, 2019
Summary
The Woman's Condom (WC) shows promising acceptability and ease of use for women seeking a female-controlled method for pregnancy and STI prevention. Most users would recommend this contraceptive option to others.
Area of Science:
- Reproductive Health
- Contraception
- Public Health
Background:
- Female-controlled barrier methods are crucial for reproductive health.
- The Woman's Condom (WC) offers a dual method for pregnancy and STI prevention.
- Evaluating user acceptability is key for successful contraceptive adoption.
Purpose of the Study:
- To assess the acceptability of the Woman's Condom (WC) over six months in a US-based trial.
- To evaluate user experience regarding ease of use, comfort, and satisfaction.
- To determine user confidence in the WC's ability to prevent pregnancy and STIs.
Main Methods:
- Open-label, multicenter phase III contraceptive efficacy trial.
- Acceptability assessed via questionnaires at multiple time points.
- Quantitative descriptive statistics and qualitative content analysis of open-ended responses.
Main Results:
- Most participants had no prior experience with female condoms.
- Ease of WC insertion improved over time (59% to 69%).
- High confidence reported in preventing pregnancy (81%) and STIs (72%); 85% would recommend the WC.
Conclusions:
- The Woman's Condom demonstrates promising acceptability and ease of use.
- It represents a viable female-controlled option for dual pregnancy and STI protection.
- Findings support wider dissemination of the WC as a contraceptive choice.